The largest database of trusted experimental protocols

5 protocols using saracatinib

1

Antibody Characterization for α-Synuclein Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies against cav-1 (#610407) and α-syn (#610786) were purchased from BD Biosciences (Franklin Lakes, NJ). Antibodies against human α-syn (#ab138501), Tuj-1 (#ab18207) and mCherry (#ab167453) were purchased from Abcam (Cambridge, MA). Antibodies against pCav-1 (#3251S), pSrc (Y416) (#6943), and c-Src (#2123) were purchased from Cell signaling Technology (Danvers, MA). Antibody against GAPDH (#SC-32233) was procured from Santa Cruz Biotechnology (Santa Cruz, CA). Rhodamine-conjugated transferrin (#T23365) and boron-dipyrromethene (BODIPY) FL C5-LacCer (#B34402) were purchased from Molecular Probes (Leiden, The Netherlands). Saracatinib (#11497) was procured from Cayman Chemical (Ann Arbor, MI). SKI-1 (c-Src inhibitor 1, #S2075), retinoic acid (RA) (#r2625), and bafilomycin A1 (#B1793) were obtained from Sigma (St. Louis, MO). Antibodies against Iba-1 (#019-19741) and pSer 129 α-syn (#015-25191) was purchased from Wako (Richmond, VA). Antibody against glial fibrillary acidic protein (GFAP) (#RA22101) was purchased from Neuromics (Montreal, QC). Recombinant α-syn monomers and fibrils were prepared as described previously [24 (link)]. The status of fibrils was determined by thioflavin T binding assay.
+ Open protocol
+ Expand
2

Epithelial and Colonic Injury Induction

Check if the same lab product or an alternative is used in the 5 most similar protocols
To induce epithelial injury, hydroxyurea, 5-fluorouracil, and doxorubicin (Sigma) were administered intraperitoneally at a dose of 1g/kg, 150mg/kg, and 15mg/kg, respectively. To induce colonic injury, 2% dextran sodium sulfate (DSS) was given for 5 days. For Lgr5+ cell ablation, DT was administered via intraperitoneal injection at a dose of 50ug/kg. Whole body irradiation at a dose of 10 or 12 Gy was given to some mice. Src inhibitor (Saracatinib, Caymanchemicals) and γ-secretase inhibitor dibenzazepine (DBZ, Tocris BioScience) were administered at indicated time points orally at a dose of 50mg/kg and intraperitonially at a dose of 5 mg/kg, respectively. Bone marrow transplantation and EdU label retention assay was performed as described previously23 (link), 24 (link).
More detailed information is described in Supplementary Methods.
+ Open protocol
+ Expand
3

Tyrosine Phosphorylation and PDHA1 Mutants

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293, SW480, SW620 and 4T1 cells were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% bovine calf serum. AsPC1 cells were cultured in RPMI-1640 medium with 10% fetal bovine serum (FBS). MCF-10A cells were grown in DMEM/F12 with 5% Horse Serum, 20ng/ml EGF, 0.5 mg/ml Hydrocortisone, 10μg/ml Insulin. Src inhibitors PP2, SU6656 and Saracatinib were purchased from Cayman Chemical, and chemodrug Doxorubicin from Sigma. Mouse and rabbit phospho-tyrosine (P-Tyr-1000 and P-Tyr-100) and PDHA1 monoclonal antibodies were from Cell Signaling. Mouse monoclonal Flag M2 antibody was from Sigma. PDHA1 AAA mutant was created by substituting three serine residues (S293, S300, and S232) with alanine. PDHA1 Y289F mutant was generated by replacing tyrosine 289 with phenylalanine. Mutagenesis was achieved using a method described in QuickChange II Site-Directed Mutagenesis (Stratagene).
+ Open protocol
+ Expand
4

Pathway Inhibitors Modulate Cellular Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
All three FAK family inhibitors (PF-431396, PF-562271, and PF-573228) and Pan-Src kinase inhibitor (Saracatinib) were purchased from Cayman Chemicals. Src kinase inhibitor PP2 and Smad3 inhibitor (SIS3) were purchased from Tocris of R&D Systems. ROCK inhibitor (Y-27632), Cdc42 GTPase inhibitor (ML-141), and Rac1/3 inhibitor (EHop-016) were purchased from Selleckchem. YAP-TEAD inhibitor (Verteporfin) was purchased from Cayman Chemicals (USA) and Selleckchem. Anti-FAK was purchased from Millipore. Antibodies against p-FAK(Y397), p-PYK2(Y402), PYK2, c-Src, p-Src(Y416), Smad2, p-Smad2(S465/467), p-Smad3(S423/425), Smad3, and YAP/TAZ were purchased from Cell Signaling Technology. anti-α-SMA and anti-actin were Sigma-Korea. Antibodies to detect p-PYK2(Y402), p-PYK2(Y579/580), and p-PYK2(Y881) were purchased from Invitrogen. Anti-CTGF and anti-myc-tag were purchased from Abcam. Anti-YAP and anti-α-SMA were purchased from Santa Cruz Biotechnology and Dako, respectively. Secondary antibodies to detect the primary antibodies were purchased as followed; HRP-conjugated anti-rabbit and anti-mouse from Pierce-Thermo Scientific, all Alexa-fluorophore conjugated antibodies from Invitrogen.
+ Open protocol
+ Expand
5

Antibody Characterization and Protein Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies against cav-1 (#610407) and α-syn (#610786) were purchased from BD Biosciences (Franklin Lakes, NJ). Antibodies against human α-syn (#ab138501), and mCherry (#ab167453) were purchased from Abcam (Cambridge, MA). Antibody against pCav-1 (#3251S) was purchased from Cell signaling Technology (Danvers, MA). Antibody against GAPDH (#SC-32233) was procured from Santa Cruz Biotechnology (Santa Cruz, CA). Rhodamine-conjugated transferrin (#T23365) and boron-dipyrromethene (BODIPY) FL C5-LacCer (#B34402) were purchased from Molecular Probes (Leiden, The Netherlands).
Saracatinib (#11497) was procured from Cayman Chemical (Ann Arbor, MI). SKI-1 (c-Src inhibitor 1, #S2075), retinoic acid (RA) (#r2625), and ba lomycin A1 (#B1793) were obtained from Sigma (St. Louis, MO). Antibody for pSer 129 α-syn (#015-25191) was purchased from Wako (Richmond, VA).
Recombinant α-syn monomers and brils were prepared as described previously [24] . Aβ (#RP10017) was purchased from GenScript (Piscataway, NJ). Aβ brils were prepared as described previously [25] . The status of brils was determined by thio avin T binding assay.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!